Skip to main content
×
×
Home

Mouse studies on inhibitors of Plasmodium falciparum Hsp90: progress and challenges

  • ABEBE GENETU BAYIH (a1) (a2) and DYLAN R. PILLAI (a1) (a2)
Summary

This review highlights studies conducted in murine models to evaluate the efficacy of compounds targeting Heat shock protein (Hsp) 90 of malaria. Both advances achieved and limitations that exist are highlighted.

Copyright
Corresponding author
* Corresponding author: University of Calgary, Diagnostic & Scientific Centre, Room 1W-416, 9-3535 Research Road NW, Calgary, AB T2L 2K8, Canada. E-mail: dylanrpillai@gmail.com
References
Hide All
Acharya, P., Kumar, R. and Tatu, U. (2007). Chaperoning a cellular upheaval in malaria: heat shock proteins in Plasmodium falciparum . Molecular and Biochemical Parasitology 153, 8594. doi: 10.1016/j.molbiopara.2007.01.009.
Ancolio, C., Azas, N., Mahiou, V., Ollivier, E., Di Giorgio, C., Keita, A., Timon-David, P. and Balansard, G. (2002). Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome. Phytotherapy Research 16, 646649. doi: 10.1002/ptr.1025.
Angulo-Barturen, I., Jimenez-Diaz, M. B., Mulet, T., Rullas, J., Herreros, E., Ferrer, S., Jimenez, E., Mendoza, A., Regadera, J., Rosenthal, P. J., Bathurst, I., Pompliano, D. L., Gomez de las Heras, F. and Gargallo-Viola, D. (2008). A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. PloS One 3, e2252. doi: 10.1371/journal.pone.0002252.
Azas, N., Laurencin, N., Delmas, F., Di, G. C., Gasquet, M., Laget, M. and Timon-David, P. (2002). Synergistic in vitro antimalarial activity of plant extracts used as traditional herbal remedies in Mali. Parasitology Research 88, 165171.
Banumathy, G., Singh, V., Pavithra, S. R. and Tatu, U. (2003). Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes. Journal of Biological Chemistry 278, 1833618345. doi: 10.1074/jbc.M211309200.
Beeson, J. G. and Brown, G. V. (2002). Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation. Cellular and Molecular Life Sciences 59, 258271.
Bonnefoy, S., Attal, G., Langsley, G., Tekaia, F. and Mercereau-Puijalon, O. (1994). Molecular characterization of the heat shock protein 90 gene of the human malaria parasite Plasmodium falciparum . Molecular and Biochemical Parasitology 67, 157170.
Bracher, A. and Hartl, F. U. (2006). Hsp90 structure: when two ends meet. Nature Structural and Molecular Biology 13, 478480. doi: 10.1038/nsmb0606-478.
ClinicalTrials.gov (2013). The first-in-human phase i trial of PU-H71 in patients with advanced malignancies. ClinicalTrials.gov.
Csermely, P., Schnaider, T., Soti, C., Prohaszka, Z. and Nardai, G. (1998). The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacology and Therapeutics 79, 129168.
DeBoer, C., Meulman, P. A., Wnuk, R. J. and Peterson, D. H. (1970). Geldanamycin, a new antibiotic. Journal of Antibiotics 23, 442447.
Fidock, D. A., Rosenthal, P. J., Croft, S. L., Brun, R. and Nwaka, S. (2004). Antimalarial drug discovery: efficacy models for compound screening. Nature Reviews. Drug Discovery 3, 509520. doi: 10.1038/nrd1416.
He, H., Zatorska, D., Kim, J., Aguirre, J., Llauger, L., She, Y., Wu, N., Immormino, R. M., Gewirth, D. T. and Chiosis, G. (2006). Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90. Journal of Medicinal Chemistry 49, 381390. doi: 10.1021/jm0508078.
Jhaveri, K., Taldone, T., Modi, S. and Chiosis, G. (2012). Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers. Biochimica et Biophysica Acta 1823, 742755. doi: 10.1016/j.bbamcr.2011.10.008.
Jimenez-Diaz, M. B., Mulet, T., Viera, S., Gomez, V., Garuti, H., Ibanez, J., Alvarez-Doval, A., Shultz, L. D., Martinez, A., Gargallo-Viola, D. and Angulo-Barturen, I. (2009). Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes. Antimicrobial Agents and Chemotherapy 53, 45334536. doi: 10.1128/AAC.00519-09.
Kumar, R., Musiyenko, A. and Barik, S. (2003). The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin. Malaria Journal 2, 30. doi: 10.1186/1475-2875-2-30.
Lindquist, S. and Craig, E. A. (1988). The heat-shock proteins. Annual Review of Genetics 22, 631677. doi: 10.1146/annurev.ge.22.120188.003215.
Mout, R., Xu, Z. D., Wolf, A. K., Jo Davisson, V. and Jarori, G. K. (2012). Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii . Malaria Journal 11, 54. doi: 10.1186/1475-2875-11-54.
Neckers, L. and Tatu, U. (2008). Molecular chaperones in pathogen virulence: emerging new targets for therapy. Cell Host and Microbe 4, 519527. doi: 10.1016/j.chom.2008.10.011.
Pallavi, R., Roy, N., Nageshan, R. K., Talukdar, P., Pavithra, S. R., Reddy, R., Venketesh, S., Kumar, R., Gupta, A. K., Singh, R. K., Yadav, S. C. and Tatu, U. (2010). Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug. Journal of Biological Chemistry 285, 3796437975. doi: 10.1074/jbc.M110.155317.
Peters, W., Howells, R. E., Portus, J., Robinson, B. L., Thomas, S. and Warhurst, D. C. (1977). The chemotherapy of rodent malaria, XXVII. Studies on mefloquine (WR 142,490). Annals of Tropical Medicine and Parasitology 71, 407418.
Peters, W., Robinson, B. L. and Ellis, D. S. (1987). The chemotherapy of rodent malaria. XLII. Halofantrine and halofantrine resistance. Annals of Tropical Medicine and Parasitology 81, 639646.
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W. and Pearl, L. H. (1997). Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90, 6575.
Sanni, L. A., Fonseca, L. F. and Langhorne, J. (2002). Mouse models for erythrocytic-stage malaria. Methods in Molecular Medicine 72, 5776. doi: 10.1385/1-59259-271-6:57.
Sasaki, K., Yasuda, H. and Onodera, K. (1979). Growth inhibition of virus transformed cells in vitro and antitumor activity in vivo of geldanamycin and its derivatives. Journal of Antibiotics 32, 849851.
Scheibel, T. and Buchner, J. (1998). The Hsp90 complex – a super-chaperone machine as a novel drug target. Biochemical Pharmacology 56, 675682.
Shahinas, D., Liang, M., Datti, A. and Pillai, D. R. (2010). A repurposing strategy identifies novel synergistic inhibitors of Plasmodium falciparum heat shock protein 90. Journal of Medicinal Chemistry 53, 35523557. doi: 10.1021/jm901796s.
Shahinas, D., Macmullin, G., Benedict, C., Crandall, I. and Pillai, D. R. (2012). Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin. Antimicrobial Agents and Chemotherapy 56, 42074213. doi: 10.1128/AAC.00328-12.
Shahinas, D., Folefoc, A., Taldone, T., Chiosis, G., Crandall, I. and Pillai, D. R. (2013). A purine analog synergizes with chloroquine (CQ) by targeting Plasmodium falciparum Hsp90 (PfHsp90). PloS One 8, e75446. doi: 10.1371/journal.pone.0075446.
Shonhai, A. (2010). Plasmodial heat shock proteins: targets for chemotherapy. FEMS Immunology and Medical Microbiology 58, 6174. doi: 10.1111/j.1574-695X.2009.00639.x.
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E. and Neckers, L. M. (1994). Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proceedings of the National Academy of Sciences USA 91, 83248328.
Wiech, H., Buchner, J., Zimmermann, R. and Jakob, U. (1992). Hsp90 chaperones protein folding in vitro . Nature 358, 169170. doi: 10.1038/358169a0.
World Health Organization (2013). Malaria. In Fact Sheet, Vol. 94. World Health Organization, Geneva, Switzerland.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Parasitology
  • ISSN: 0031-1820
  • EISSN: 1469-8161
  • URL: /core/journals/parasitology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 2
Total number of PDF views: 31 *
Loading metrics...

Abstract views

Total abstract views: 230 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th August 2018. This data will be updated every 24 hours.